Improving healthcare through innovation
Microbiome is active in the discovery, development, manufacturing and marketing of innovative molecular microbiological techniques, tools, systems,
kits and characterizations.
Aeras and the Infectious Disease Research Institute (IDRI) announce today the start of the first clinical trial of IDRI's novel tuberculosis vaccine candidate,... read more >
Recent research explains why treating gonorrhea has grown more difficult. Scientists from Harvard University, the Centers for Disease Control and Prevention... read more >
Partners of Microbiome
We develop integrated solutions together with leading manufacturers from the diagnostics and pharmaceutical industries, helping them to leverage our leading sample & assay technologies as part of their own offerings. read more >